These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32686015)

  • 21. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2019; 42(6):189-196. PubMed ID: 31725473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone in combination with other drugs: Experimental research in individuals with autism spectrum disorder.
    Li A; MacNeill B; Curiel H; Poling A
    Exp Clin Psychopharmacol; 2017 Oct; 25(5):434-439. PubMed ID: 29048191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Autism Spectrum Disorder in Children and Adolescents.
    DeFilippis M; Wagner KD
    Psychopharmacol Bull; 2016 Aug; 46(2):18-41. PubMed ID: 27738378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing irritability and aggression in autism spectrum disorders in children and adolescents.
    Robb AS
    Dev Disabil Res Rev; 2010; 16(3):258-64. PubMed ID: 20981764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on pharmacotherapy of autism spectrum disorder in children and adolescents.
    Goel R; Hong JS; Findling RL; Ji NY
    Int Rev Psychiatry; 2018 Feb; 30(1):78-95. PubMed ID: 29693461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
    Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duchenne Muscular Dystrophy Successfully Treated with Aripiprazole in a Patient with Autism Spectrum Disorder Symptoms Including Irritability.
    Noda S; Murakami A; Kimura S; Minamiyama M; Katsuno M; Kuru S
    Intern Med; 2021 Dec; 60(24):3983-3986. PubMed ID: 34148958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study.
    Fusar-Poli L; Brondino N; Rocchetti M; Petrosino B; Arillotta D; Damiani S; Provenzani U; Petrosino C; Aguglia E; Politi P
    Psychiatry Res; 2019 Jun; 276():203-209. PubMed ID: 31102885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders.
    Canitano R
    Clin Neuropharmacol; 2015; 38(5):177-82. PubMed ID: 26366961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychopharmacology Management in Autism Spectrum Disorder.
    Salpekar JA; Scahill L
    Pediatr Clin North Am; 2024 Apr; 71(2):283-299. PubMed ID: 38423721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autism Spectrum Disorder: A Review.
    Hirota T; King BH
    JAMA; 2023 Jan; 329(2):157-168. PubMed ID: 36625807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Introduction to the Psychopharmacology of Children and Adolescents With Autism Spectrum Disorder.
    Earle JF
    J Child Adolesc Psychiatr Nurs; 2016 May; 29(2):62-71. PubMed ID: 27279529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychopharmacological interventions in autism spectrum disorder.
    Politte LC; Henry CA; McDougle CJ
    Harv Rev Psychiatry; 2014; 22(2):76-92. PubMed ID: 24614763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The psychopharmacology algorithm project at the Harvard South Shore Program: An algorithm for core symptoms of autism spectrum disorder in adults.
    Gannon S; Osser DN
    Psychiatry Res; 2020 May; 287():112900. PubMed ID: 32179209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder.
    Henneberry E; Lamy M; Dominick KC; Erickson CA
    J Autism Dev Disord; 2021 Dec; 51(12):4370-4394. PubMed ID: 34491511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on medication management of behavioral disorders in autism.
    Baribeau DA; Anagnostou E
    Curr Psychiatry Rep; 2014 Mar; 16(3):437. PubMed ID: 24488702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder.
    Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Jones B; von Hurst PR
    J Steroid Biochem Mol Biol; 2019 Mar; 187():9-16. PubMed ID: 30744880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response.
    Salazar de Pablo G; Pastor Jordá C; Vaquerizo-Serrano J; Moreno C; Cabras A; Arango C; Hernández P; Veenstra-VanderWeele J; Simonoff E; Fusar-Poli P; Santosh P; Cortese S; Parellada M
    J Am Acad Child Adolesc Psychiatry; 2023 Feb; 62(2):151-168. PubMed ID: 35470032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid treatment for the symptoms of autism spectrum disorder.
    Aran A; Cayam Rand D
    Expert Opin Emerg Drugs; 2024 Mar; 29(1):65-79. PubMed ID: 38226593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.